Loading clinical trials...
Loading clinical trials...
Development of Non-invasive Prenatal Test for Microdeletion/Duplication and Other Genetic Syndromes Based on Fetal DNA Isolated From Maternal Blood
Conditions
Locations
2
United States
Natera
San Carlos, California, United States
Children's Hospital Of Philadelphia
Philadelphia, Pennsylvania, United States
Start Date
October 1, 2012
Primary Completion Date
June 1, 2019
Completion Date
August 1, 2019
Last Updated
August 26, 2019
NCT07234695
NCT07413224
NCT07195253
NCT05981521
NCT05004337
NCT02872948
Lead Sponsor
Natera, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions